Y-mAbs Therapeutics Inc. (YMAB)

YMAB trades at $8.61, 244.4% above the near-term max pain of $2.5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$9), signaling increased put positioning or downside protection. Key magnetic zone at 8 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for YMAB shows a downward trend from 9 to 2.5, indicating bearish sentiment or hedging activity. The 98% spread signals divergent expectations across timeframes. Most levels below 8.61 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.